The Impact of Prolonged Use of Continuous Glucose Monitoring Sensors in Patients with Diabetes Mellitus: Accuracy and Financial Burden
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F19%3A00336576" target="_blank" >RIV/68407700:21460/19:00336576 - isvavai.cz</a>
Výsledek na webu
<a href="https://doi.org/10.1109/EHB47216.2019.8969876" target="_blank" >https://doi.org/10.1109/EHB47216.2019.8969876</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1109/EHB47216.2019.8969876" target="_blank" >10.1109/EHB47216.2019.8969876</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The Impact of Prolonged Use of Continuous Glucose Monitoring Sensors in Patients with Diabetes Mellitus: Accuracy and Financial Burden
Popis výsledku v původním jazyce
According to IDF, the worldwide cost of treating diabetes mellitus (DM) in patients aged 20 to 79 years is estimated at 727 million USD. The aim of this study was to conduct a pilot investigation of the impact of prolonged use of the continuous glucose monitoring sensors on the measurement accuracy and on the costs associated with these sensors. Data from 10 patients with type I DM who used the CGM sensor for a prolonged period beyond the expiration date specified by the manufacturer were used for analysis and statistical processing. The Enlite and Dexcom sensors partially or fully covered by public health insurance in the Czech Republic were used. A total of 453 measurements were analyzed. Nonparametric statistic tests were used for statistical data processing. The study results shown that the prolongation of the sensor usage time does not have a significant influence on the accuracy of its measurement. At the same time, it was confirmed that there was a statistically significant difference between the values of glycemia measured by CGM and the blood glucose level measured by personal glucometer. The cost reduction of 30-85% could be achieved in case of prolonged use of CGM sensors (from 6-7 days to 10 days), depending on the sensor type and age group of the patient.
Název v anglickém jazyce
The Impact of Prolonged Use of Continuous Glucose Monitoring Sensors in Patients with Diabetes Mellitus: Accuracy and Financial Burden
Popis výsledku anglicky
According to IDF, the worldwide cost of treating diabetes mellitus (DM) in patients aged 20 to 79 years is estimated at 727 million USD. The aim of this study was to conduct a pilot investigation of the impact of prolonged use of the continuous glucose monitoring sensors on the measurement accuracy and on the costs associated with these sensors. Data from 10 patients with type I DM who used the CGM sensor for a prolonged period beyond the expiration date specified by the manufacturer were used for analysis and statistical processing. The Enlite and Dexcom sensors partially or fully covered by public health insurance in the Czech Republic were used. A total of 453 measurements were analyzed. Nonparametric statistic tests were used for statistical data processing. The study results shown that the prolongation of the sensor usage time does not have a significant influence on the accuracy of its measurement. At the same time, it was confirmed that there was a statistically significant difference between the values of glycemia measured by CGM and the blood glucose level measured by personal glucometer. The cost reduction of 30-85% could be achieved in case of prolonged use of CGM sensors (from 6-7 days to 10 days), depending on the sensor type and age group of the patient.
Klasifikace
Druh
D - Stať ve sborníku
CEP obor
—
OECD FORD obor
20601 - Medical engineering
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2019
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název statě ve sborníku
IEEE E-HEALTH AND BIOENGINEERING EHB 2019
ISBN
978-1-7281-2603-6
ISSN
—
e-ISSN
2575-5145
Počet stran výsledku
4
Strana od-do
—
Název nakladatele
Gr. T. Popa University of Medicine and Pharmacy
Místo vydání
Iasi
Místo konání akce
Iasi
Datum konání akce
21. 11. 2019
Typ akce podle státní příslušnosti
WRD - Celosvětová akce
Kód UT WoS článku
000558648300008